Registry-listed formulations

Ornidazole · chembl:CHEMBL1449676

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

2 source entries across 2 studies. This list may not include all unresolved or historical entries.

  • Oral OrnidazoleRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Oral OrnidazoleRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Not Applicable
2
40%
Phase 3
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
3(60.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Not yet recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (60.0%)
N/A2 (40.0%)

Trials by Status

completed240%
terminated120%
not_yet_recruiting240%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
5

External References

Names & Codes

ATC Classification

Research Codes

NSC-95075RO 7-0207